カテゴリー： LP Information, 世界, 医療/バイオ

H1受容体拮抗薬のグローバル市場予測2023-2029

◆英語タイトル：Global H1 Receptor Antagonist Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23OT8945）◆商品コード：LP23OT8945
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年10月
◆ページ数：116
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「H1受容体拮抗薬のグローバル市場」は、過去の販売実績から2022年の世界のH1受容体拮抗薬の総販売量を検討し、2023年から2029年の予測されるH1受容体拮抗薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のH1受容体拮抗薬の市場規模を掲載し、XXX百万米ドル規模の世界のH1受容体拮抗薬市場の詳細な分析を提供します。本インサイトレポートは、世界のH1受容体拮抗薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のH1受容体拮抗薬市場における各社の独自のポジションをより深く理解するために、H1受容体拮抗薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のH1受容体拮抗薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。H1受容体拮抗薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。H1受容体拮抗薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。H1受容体拮抗薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

H1受容体拮抗薬の世界主要メーカーとしては、Teva、 Bayer、 Pfizer、 LETI、 Novartis、 Hypera Pharma、 Woodward、 Merck、 Johnson and Johnson、 Ethical pharma、 Gems pharma、 KPL Pharma、 GlaxoSmithKline、 Ying Yuan、 Schering-Ploughなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のH1受容体拮抗薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査ではH1受容体拮抗薬市場をセグメンテーションし、種類別 (第一世代 H1RAS、第二世代 H1RAS、第三世代 H1RAS)、用途別 (病院、薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：第一世代 H1RAS、第二世代 H1RAS、第三世代 H1RAS

・用途別区分：病院、薬局、その他

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のH1受容体拮抗薬市場の10年間の市場状況・展望は？
・世界および地域別に見たH1受容体拮抗薬市場成長の要因は何か？
・H1受容体拮抗薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・H1受容体拮抗薬のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：H1受容体拮抗薬の年間販売量2018-2029、地域別現状・将来分析
・H1受容体拮抗薬の種類別セグメント：第一世代 H1RAS、第二世代 H1RAS、第三世代 H1RAS
・H1受容体拮抗薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・H1受容体拮抗薬の用途別セグメント：病院、薬局、その他
・H1受容体拮抗薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のH1受容体拮抗薬市場
・企業別のグローバルH1受容体拮抗薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別のH1受容体拮抗薬の年間売上：2018-2023年の売上、市場シェア
・企業別のH1受容体拮抗薬販売価格
・主要企業のH1受容体拮抗薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

H1受容体拮抗薬の地域別レビュー
・地域別のH1受容体拮抗薬市場規模2018-2023：年間販売量、売上
・主要国別のH1受容体拮抗薬市場規模2018-2023：年間販売量、売上
・南北アメリカのH1受容体拮抗薬販売の成長
・アジア太平洋のH1受容体拮抗薬販売の成長
・ヨーロッパのH1受容体拮抗薬販売の成長
・中東・アフリカのH1受容体拮抗薬販売の成長

南北アメリカ市場
・南北アメリカの国別のH1受容体拮抗薬販売量、売上（2018-2023）
・南北アメリカのH1受容体拮抗薬の種類別販売量
・南北アメリカのH1受容体拮抗薬の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のH1受容体拮抗薬販売量、売上（2018-2023）
・アジア太平洋のH1受容体拮抗薬の種類別販売量
・アジア太平洋のH1受容体拮抗薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のH1受容体拮抗薬販売量、売上（2018-2023）
・ヨーロッパのH1受容体拮抗薬の種類別販売量
・ヨーロッパのH1受容体拮抗薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のH1受容体拮抗薬販売量、売上（2018-2023）
・中東・アフリカのH1受容体拮抗薬の種類別販売量
・中東・アフリカのH1受容体拮抗薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・H1受容体拮抗薬の製造コスト構造分析
・H1受容体拮抗薬の製造プロセス分析
・H1受容体拮抗薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・H1受容体拮抗薬の主要なグローバル販売業者
・H1受容体拮抗薬の主要なグローバル顧客

地域別のH1受容体拮抗薬市場予測レビュー
・地域別のH1受容体拮抗薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・H1受容体拮抗薬の種類別市場規模予測
・H1受容体拮抗薬の用途別市場規模予測

主要企業分析
Teva、 Bayer、 Pfizer、 LETI、 Novartis、 Hypera Pharma、 Woodward、 Merck、 Johnson and Johnson、 Ethical pharma、 Gems pharma、 KPL Pharma、 GlaxoSmithKline、 Ying Yuan、 Schering-Plough
・企業情報
・H1受容体拮抗薬製品
・H1受容体拮抗薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global H1 Receptor Antagonist Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for H1 Receptor Antagonist by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for H1 Receptor Antagonist by Country/Region, 2018, 2022 & 2029
2.2 H1 Receptor Antagonist Segment by Type
2.2.1 First Generation H1RAS
2.2.2 Second-generation H1RAS
2.2.3 Third-generation H1RAS
2.3 H1 Receptor Antagonist Sales by Type
2.3.1 Global H1 Receptor Antagonist Sales Market Share by Type (2018-2023)
2.3.2 Global H1 Receptor Antagonist Revenue and Market Share by Type (2018-2023)
2.3.3 Global H1 Receptor Antagonist Sale Price by Type (2018-2023)
2.4 H1 Receptor Antagonist Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 H1 Receptor Antagonist Sales by Application
2.5.1 Global H1 Receptor Antagonist Sale Market Share by Application (2018-2023)
2.5.2 Global H1 Receptor Antagonist Revenue and Market Share by Application (2018-2023)
2.5.3 Global H1 Receptor Antagonist Sale Price by Application (2018-2023)
3 Global H1 Receptor Antagonist by Company
3.1 Global H1 Receptor Antagonist Breakdown Data by Company
3.1.1 Global H1 Receptor Antagonist Annual Sales by Company (2018-2023)
3.1.2 Global H1 Receptor Antagonist Sales Market Share by Company (2018-2023)
3.2 Global H1 Receptor Antagonist Annual Revenue by Company (2018-2023)
3.2.1 Global H1 Receptor Antagonist Revenue by Company (2018-2023)
3.2.2 Global H1 Receptor Antagonist Revenue Market Share by Company (2018-2023)
3.3 Global H1 Receptor Antagonist Sale Price by Company
3.4 Key Manufacturers H1 Receptor Antagonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers H1 Receptor Antagonist Product Location Distribution
3.4.2 Players H1 Receptor Antagonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for H1 Receptor Antagonist by Geographic Region
4.1 World Historic H1 Receptor Antagonist Market Size by Geographic Region (2018-2023)
4.1.1 Global H1 Receptor Antagonist Annual Sales by Geographic Region (2018-2023)
4.1.2 Global H1 Receptor Antagonist Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic H1 Receptor Antagonist Market Size by Country/Region (2018-2023)
4.2.1 Global H1 Receptor Antagonist Annual Sales by Country/Region (2018-2023)
4.2.2 Global H1 Receptor Antagonist Annual Revenue by Country/Region (2018-2023)
4.3 Americas H1 Receptor Antagonist Sales Growth
4.4 APAC H1 Receptor Antagonist Sales Growth
4.5 Europe H1 Receptor Antagonist Sales Growth
4.6 Middle East & Africa H1 Receptor Antagonist Sales Growth
5 Americas
5.1 Americas H1 Receptor Antagonist Sales by Country
5.1.1 Americas H1 Receptor Antagonist Sales by Country (2018-2023)
5.1.2 Americas H1 Receptor Antagonist Revenue by Country (2018-2023)
5.2 Americas H1 Receptor Antagonist Sales by Type
5.3 Americas H1 Receptor Antagonist Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC H1 Receptor Antagonist Sales by Region
6.1.1 APAC H1 Receptor Antagonist Sales by Region (2018-2023)
6.1.2 APAC H1 Receptor Antagonist Revenue by Region (2018-2023)
6.2 APAC H1 Receptor Antagonist Sales by Type
6.3 APAC H1 Receptor Antagonist Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe H1 Receptor Antagonist by Country
7.1.1 Europe H1 Receptor Antagonist Sales by Country (2018-2023)
7.1.2 Europe H1 Receptor Antagonist Revenue by Country (2018-2023)
7.2 Europe H1 Receptor Antagonist Sales by Type
7.3 Europe H1 Receptor Antagonist Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa H1 Receptor Antagonist by Country
8.1.1 Middle East & Africa H1 Receptor Antagonist Sales by Country (2018-2023)
8.1.2 Middle East & Africa H1 Receptor Antagonist Revenue by Country (2018-2023)
8.2 Middle East & Africa H1 Receptor Antagonist Sales by Type
8.3 Middle East & Africa H1 Receptor Antagonist Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of H1 Receptor Antagonist
10.3 Manufacturing Process Analysis of H1 Receptor Antagonist
10.4 Industry Chain Structure of H1 Receptor Antagonist
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 H1 Receptor Antagonist Distributors
11.3 H1 Receptor Antagonist Customer
12 World Forecast Review for H1 Receptor Antagonist by Geographic Region
12.1 Global H1 Receptor Antagonist Market Size Forecast by Region
12.1.1 Global H1 Receptor Antagonist Forecast by Region (2024-2029)
12.1.2 Global H1 Receptor Antagonist Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global H1 Receptor Antagonist Forecast by Type
12.7 Global H1 Receptor Antagonist Forecast by Application
13 Key Players Analysis
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva H1 Receptor Antagonist Product Portfolios and Specifications
13.1.3 Teva H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer H1 Receptor Antagonist Product Portfolios and Specifications
13.2.3 Bayer H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer H1 Receptor Antagonist Product Portfolios and Specifications
13.3.3 Pfizer H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 LETI
13.4.1 LETI Company Information
13.4.2 LETI H1 Receptor Antagonist Product Portfolios and Specifications
13.4.3 LETI H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 LETI Main Business Overview
13.4.5 LETI Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis H1 Receptor Antagonist Product Portfolios and Specifications
13.5.3 Novartis H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Hypera Pharma
13.6.1 Hypera Pharma Company Information
13.6.2 Hypera Pharma H1 Receptor Antagonist Product Portfolios and Specifications
13.6.3 Hypera Pharma H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hypera Pharma Main Business Overview
13.6.5 Hypera Pharma Latest Developments
13.7 Woodward
13.7.1 Woodward Company Information
13.7.2 Woodward H1 Receptor Antagonist Product Portfolios and Specifications
13.7.3 Woodward H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Woodward Main Business Overview
13.7.5 Woodward Latest Developments
13.8 Merck
13.8.1 Merck Company Information
13.8.2 Merck H1 Receptor Antagonist Product Portfolios and Specifications
13.8.3 Merck H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Merck Main Business Overview
13.8.5 Merck Latest Developments
13.9 Johnson and Johnson
13.9.1 Johnson and Johnson Company Information
13.9.2 Johnson and Johnson H1 Receptor Antagonist Product Portfolios and Specifications
13.9.3 Johnson and Johnson H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Johnson and Johnson Main Business Overview
13.9.5 Johnson and Johnson Latest Developments
13.10 Ethical pharma
13.10.1 Ethical pharma Company Information
13.10.2 Ethical pharma H1 Receptor Antagonist Product Portfolios and Specifications
13.10.3 Ethical pharma H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ethical pharma Main Business Overview
13.10.5 Ethical pharma Latest Developments
13.11 Gems pharma
13.11.1 Gems pharma Company Information
13.11.2 Gems pharma H1 Receptor Antagonist Product Portfolios and Specifications
13.11.3 Gems pharma H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Gems pharma Main Business Overview
13.11.5 Gems pharma Latest Developments
13.12 KPL Pharma
13.12.1 KPL Pharma Company Information
13.12.2 KPL Pharma H1 Receptor Antagonist Product Portfolios and Specifications
13.12.3 KPL Pharma H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 KPL Pharma Main Business Overview
13.12.5 KPL Pharma Latest Developments
13.13 GlaxoSmithKline
13.13.1 GlaxoSmithKline Company Information
13.13.2 GlaxoSmithKline H1 Receptor Antagonist Product Portfolios and Specifications
13.13.3 GlaxoSmithKline H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 GlaxoSmithKline Main Business Overview
13.13.5 GlaxoSmithKline Latest Developments
13.14 Ying Yuan
13.14.1 Ying Yuan Company Information
13.14.2 Ying Yuan H1 Receptor Antagonist Product Portfolios and Specifications
13.14.3 Ying Yuan H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Ying Yuan Main Business Overview
13.14.5 Ying Yuan Latest Developments
13.15 Schering-Plough
13.15.1 Schering-Plough Company Information
13.15.2 Schering-Plough H1 Receptor Antagonist Product Portfolios and Specifications
13.15.3 Schering-Plough H1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Schering-Plough Main Business Overview
13.15.5 Schering-Plough Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. H1 Receptor Antagonist Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. H1 Receptor Antagonist Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of First Generation H1RAS
Table 4. Major Players of Second-generation H1RAS
Table 5. Major Players of Third-generation H1RAS
Table 6. Global H1 Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 7. Global H1 Receptor Antagonist Sales Market Share by Type (2018-2023)
Table 8. Global H1 Receptor Antagonist Revenue by Type (2018-2023) & ($ million)
Table 9. Global H1 Receptor Antagonist Revenue Market Share by Type (2018-2023)
Table 10. Global H1 Receptor Antagonist Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global H1 Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 12. Global H1 Receptor Antagonist Sales Market Share by Application (2018-2023)
Table 13. Global H1 Receptor Antagonist Revenue by Application (2018-2023)
Table 14. Global H1 Receptor Antagonist Revenue Market Share by Application (2018-2023)
Table 15. Global H1 Receptor Antagonist Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global H1 Receptor Antagonist Sales by Company (2018-2023) & (K Units)
Table 17. Global H1 Receptor Antagonist Sales Market Share by Company (2018-2023)
Table 18. Global H1 Receptor Antagonist Revenue by Company (2018-2023) ($ Millions)
Table 19. Global H1 Receptor Antagonist Revenue Market Share by Company (2018-2023)
Table 20. Global H1 Receptor Antagonist Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers H1 Receptor Antagonist Producing Area Distribution and Sales Area
Table 22. Players H1 Receptor Antagonist Products Offered
Table 23. H1 Receptor Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global H1 Receptor Antagonist Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global H1 Receptor Antagonist Sales Market Share Geographic Region (2018-2023)
Table 28. Global H1 Receptor Antagonist Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global H1 Receptor Antagonist Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global H1 Receptor Antagonist Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global H1 Receptor Antagonist Sales Market Share by Country/Region (2018-2023)
Table 32. Global H1 Receptor Antagonist Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global H1 Receptor Antagonist Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas H1 Receptor Antagonist Sales by Country (2018-2023) & (K Units)
Table 35. Americas H1 Receptor Antagonist Sales Market Share by Country (2018-2023)
Table 36. Americas H1 Receptor Antagonist Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas H1 Receptor Antagonist Revenue Market Share by Country (2018-2023)
Table 38. Americas H1 Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 39. Americas H1 Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 40. APAC H1 Receptor Antagonist Sales by Region (2018-2023) & (K Units)
Table 41. APAC H1 Receptor Antagonist Sales Market Share by Region (2018-2023)
Table 42. APAC H1 Receptor Antagonist Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC H1 Receptor Antagonist Revenue Market Share by Region (2018-2023)
Table 44. APAC H1 Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 45. APAC H1 Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 46. Europe H1 Receptor Antagonist Sales by Country (2018-2023) & (K Units)
Table 47. Europe H1 Receptor Antagonist Sales Market Share by Country (2018-2023)
Table 48. Europe H1 Receptor Antagonist Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe H1 Receptor Antagonist Revenue Market Share by Country (2018-2023)
Table 50. Europe H1 Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 51. Europe H1 Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa H1 Receptor Antagonist Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa H1 Receptor Antagonist Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa H1 Receptor Antagonist Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa H1 Receptor Antagonist Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa H1 Receptor Antagonist Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa H1 Receptor Antagonist Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of H1 Receptor Antagonist
Table 59. Key Market Challenges & Risks of H1 Receptor Antagonist
Table 60. Key Industry Trends of H1 Receptor Antagonist
Table 61. H1 Receptor Antagonist Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. H1 Receptor Antagonist Distributors List
Table 64. H1 Receptor Antagonist Customer List
Table 65. Global H1 Receptor Antagonist Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global H1 Receptor Antagonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas H1 Receptor Antagonist Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas H1 Receptor Antagonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC H1 Receptor Antagonist Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC H1 Receptor Antagonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe H1 Receptor Antagonist Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe H1 Receptor Antagonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa H1 Receptor Antagonist Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa H1 Receptor Antagonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global H1 Receptor Antagonist Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global H1 Receptor Antagonist Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global H1 Receptor Antagonist Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global H1 Receptor Antagonist Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Teva Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva H1 Receptor Antagonist Product Portfolios and Specifications
Table 81. Teva H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Bayer Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 85. Bayer H1 Receptor Antagonist Product Portfolios and Specifications
Table 86. Bayer H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Bayer Main Business
Table 88. Bayer Latest Developments
Table 89. Pfizer Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer H1 Receptor Antagonist Product Portfolios and Specifications
Table 91. Pfizer H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. LETI Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 95. LETI H1 Receptor Antagonist Product Portfolios and Specifications
Table 96. LETI H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. LETI Main Business
Table 98. LETI Latest Developments
Table 99. Novartis Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 100. Novartis H1 Receptor Antagonist Product Portfolios and Specifications
Table 101. Novartis H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Novartis Main Business
Table 103. Novartis Latest Developments
Table 104. Hypera Pharma Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 105. Hypera Pharma H1 Receptor Antagonist Product Portfolios and Specifications
Table 106. Hypera Pharma H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Hypera Pharma Main Business
Table 108. Hypera Pharma Latest Developments
Table 109. Woodward Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 110. Woodward H1 Receptor Antagonist Product Portfolios and Specifications
Table 111. Woodward H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Woodward Main Business
Table 113. Woodward Latest Developments
Table 114. Merck Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck H1 Receptor Antagonist Product Portfolios and Specifications
Table 116. Merck H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Merck Main Business
Table 118. Merck Latest Developments
Table 119. Johnson and Johnson Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 120. Johnson and Johnson H1 Receptor Antagonist Product Portfolios and Specifications
Table 121. Johnson and Johnson H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Johnson and Johnson Main Business
Table 123. Johnson and Johnson Latest Developments
Table 124. Ethical pharma Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 125. Ethical pharma H1 Receptor Antagonist Product Portfolios and Specifications
Table 126. Ethical pharma H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Ethical pharma Main Business
Table 128. Ethical pharma Latest Developments
Table 129. Gems pharma Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 130. Gems pharma H1 Receptor Antagonist Product Portfolios and Specifications
Table 131. Gems pharma H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Gems pharma Main Business
Table 133. Gems pharma Latest Developments
Table 134. KPL Pharma Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 135. KPL Pharma H1 Receptor Antagonist Product Portfolios and Specifications
Table 136. KPL Pharma H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. KPL Pharma Main Business
Table 138. KPL Pharma Latest Developments
Table 139. GlaxoSmithKline Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 140. GlaxoSmithKline H1 Receptor Antagonist Product Portfolios and Specifications
Table 141. GlaxoSmithKline H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. GlaxoSmithKline Main Business
Table 143. GlaxoSmithKline Latest Developments
Table 144. Ying Yuan Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 145. Ying Yuan H1 Receptor Antagonist Product Portfolios and Specifications
Table 146. Ying Yuan H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Ying Yuan Main Business
Table 148. Ying Yuan Latest Developments
Table 149. Schering-Plough Basic Information, H1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 150. Schering-Plough H1 Receptor Antagonist Product Portfolios and Specifications
Table 151. Schering-Plough H1 Receptor Antagonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Schering-Plough Main Business
Table 153. Schering-Plough Latest Developments
List of Figures
Figure 1. Picture of H1 Receptor Antagonist
Figure 2. H1 Receptor Antagonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global H1 Receptor Antagonist Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global H1 Receptor Antagonist Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. H1 Receptor Antagonist Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of First Generation H1RAS
Figure 10. Product Picture of Second-generation H1RAS
Figure 11. Product Picture of Third-generation H1RAS
Figure 12. Global H1 Receptor Antagonist Sales Market Share by Type in 2022
Figure 13. Global H1 Receptor Antagonist Revenue Market Share by Type (2018-2023)
Figure 14. H1 Receptor Antagonist Consumed in Hospital
Figure 15. Global H1 Receptor Antagonist Market: Hospital (2018-2023) & (K Units)
Figure 16. H1 Receptor Antagonist Consumed in Retail Pharmacy
Figure 17. Global H1 Receptor Antagonist Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 18. H1 Receptor Antagonist Consumed in Other
Figure 19. Global H1 Receptor Antagonist Market: Other (2018-2023) & (K Units)
Figure 20. Global H1 Receptor Antagonist Sales Market Share by Application (2022)
Figure 21. Global H1 Receptor Antagonist Revenue Market Share by Application in 2022
Figure 22. H1 Receptor Antagonist Sales Market by Company in 2022 (K Units)
Figure 23. Global H1 Receptor Antagonist Sales Market Share by Company in 2022
Figure 24. H1 Receptor Antagonist Revenue Market by Company in 2022 ($ Million)
Figure 25. Global H1 Receptor Antagonist Revenue Market Share by Company in 2022
Figure 26. Global H1 Receptor Antagonist Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global H1 Receptor Antagonist Revenue Market Share by Geographic Region in 2022
Figure 28. Americas H1 Receptor Antagonist Sales 2018-2023 (K Units)
Figure 29. Americas H1 Receptor Antagonist Revenue 2018-2023 ($ Millions)
Figure 30. APAC H1 Receptor Antagonist Sales 2018-2023 (K Units)
Figure 31. APAC H1 Receptor Antagonist Revenue 2018-2023 ($ Millions)
Figure 32. Europe H1 Receptor Antagonist Sales 2018-2023 (K Units)
Figure 33. Europe H1 Receptor Antagonist Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa H1 Receptor Antagonist Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa H1 Receptor Antagonist Revenue 2018-2023 ($ Millions)
Figure 36. Americas H1 Receptor Antagonist Sales Market Share by Country in 2022
Figure 37. Americas H1 Receptor Antagonist Revenue Market Share by Country in 2022
Figure 38. Americas H1 Receptor Antagonist Sales Market Share by Type (2018-2023)
Figure 39. Americas H1 Receptor Antagonist Sales Market Share by Application (2018-2023)
Figure 40. United States H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC H1 Receptor Antagonist Sales Market Share by Region in 2022
Figure 45. APAC H1 Receptor Antagonist Revenue Market Share by Regions in 2022
Figure 46. APAC H1 Receptor Antagonist Sales Market Share by Type (2018-2023)
Figure 47. APAC H1 Receptor Antagonist Sales Market Share by Application (2018-2023)
Figure 48. China H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 52. India H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe H1 Receptor Antagonist Sales Market Share by Country in 2022
Figure 56. Europe H1 Receptor Antagonist Revenue Market Share by Country in 2022
Figure 57. Europe H1 Receptor Antagonist Sales Market Share by Type (2018-2023)
Figure 58. Europe H1 Receptor Antagonist Sales Market Share by Application (2018-2023)
Figure 59. Germany H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 60. France H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa H1 Receptor Antagonist Sales Market Share by Country in 2022
Figure 65. Middle East & Africa H1 Receptor Antagonist Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa H1 Receptor Antagonist Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa H1 Receptor Antagonist Sales Market Share by Application (2018-2023)
Figure 68. Egypt H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country H1 Receptor Antagonist Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of H1 Receptor Antagonist in 2022
Figure 74. Manufacturing Process Analysis of H1 Receptor Antagonist
Figure 75. Industry Chain Structure of H1 Receptor Antagonist
Figure 76. Channels of Distribution
Figure 77. Global H1 Receptor Antagonist Sales Market Forecast by Region (2024-2029)
Figure 78. Global H1 Receptor Antagonist Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global H1 Receptor Antagonist Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global H1 Receptor Antagonist Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global H1 Receptor Antagonist Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global H1 Receptor Antagonist Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ H1受容体拮抗薬のグローバル市場予測2023-2029(Global H1 Receptor Antagonist Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • エンドセリン受容体拮抗薬のグローバル市場2023年：アンブリセンタン、ボセンタン、マシテンタン
  • 世界のアンドロゲン受容体拮抗薬市場2023年：企業・地域・タイプ・用途別分析
  • ビタミンD受容体（VDR/カルシトリオール受容体）アゴニストのグローバル市場予測2023-2029
  • オピエートきっ抗剤の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆